Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review
Journal of Diabetes · 2026-07 · 18 (7)
DOI: 10.1111/1753-0407.70251 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes, online erschienen am 29.06.2026. Verfasst von Jian-Jun Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Clonal Hematopoiesis. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KTPH STAR Grant, Singapore NMRC.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Clonal hematopoiesis (CH) refers to an expanded clonal hematopoietic cell population due to acquired mutations conferring a selective growth advantage. Once considered a premalignant hematological state, CH has now been causally associated with cardiovascular diseases (CVDs) and several aging‐related clinical conditions. Emerging evidence suggests that CH is at the intersection of aging and metabolic disorders. CH carriers exhibit a higher risk of Type 2 diabetes, potentially through the obesity–inflammation–insulin resistance axis. Moreover, CH confers a higher risk of CVD and is associated with a poorer prognosis in patients with diabetes compared to noncarriers. In addition, CH has been associated with the development of microvascular complications, including retinopathy and kidney disease in patients with diabetes, although inconsistent findings exist. Preclinical studies found that antidiabetic medication metformin might slow down clonal expansion of CH, while clinical data suggest that anti‐inflammatory medications confer better clinical outcomes for certain CH carriers, although their relevance for patients with diabetes remains to be elucidated. In this narrative review, we also briefly discuss the barriers to clinical adoption of CH detection and highlight the knowledge gaps that should be addressed in future work.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Unit, Khoo Teck Puat Hospital, Singapore.
- Duke-NUS Graduate Medical School, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
- Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore.
- Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
ORCID-Profile: Jian-Jun Liu, Resham L Gurung
Förderung
- KTPH STAR Grant
- Singapore NMRC
Zitieren
APA
Liu, J. J., Liu, S., Gurung, R. L., Lim, S. C., & Dorajoo, R. (2026). Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review. Journal of Diabetes, 18(7). https://doi.org/10.1111/1753-0407.70251
Vancouver
Liu JJ, Liu S, Gurung RL, Lim SC, Dorajoo R. Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review. Journal of Diabetes. 2026;18(7). doi:10.1111/1753-0407.70251
BibTeX
@article{Liu2026,
author = {Liu, Jian-Jun and Liu, Sylvia and Gurung, Resham L and Lim, Su Chi and Dorajoo, Rajkumar},
title = {Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {7},
doi = {10.1111/1753-0407.70251}
}
EUVIMED